To assess the potential impact of granzyme K on prostate stromal cells, BPH patient-derived fibroblast cell line BHPrS1 and primary fibroblasts derived from two BPH patients (51) were treated with granzyme K in vitro. This evidence concerns the gene GZMK and benign prostatic hyperplasia.